Federal Contractor Misconduct Database (FCMD)
Chaires et al. v. Sanofi et al. (Insulin Price Fixing)
A lawsuit accuses Sanofi, Novo Nordisk, and Eli Lilly of conspiring to drive up the price of insulin by over 150% in five years. The lawsuit claims the companies set two different prices for their insulin treatments: a publicly reported benchmark price—also known as the “sticker” price—and a lower, real price that they offer to certain bulk drug distributors, known as pharmacy benefit managers.
- Misconduct Type
- Enforcement Agency
- Contracting Party
- Court Type
- Date of Complaint